Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. Am J Clin Oncol. 2011 Apr; 34(2):150-4.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Capecitabine
Chicago
Deoxycytidine
Drug-Related Side Effects and Adverse Reactions
Female
Fluorouracil
Humans
Kidney Neoplasms
Male
Middle Aged
Molecular Targeted Therapy
Neoplasm Metastasis
Survival Analysis
authors with profiles
Walter M. Stadler
Olwen Hahn
Theodore Karrison